A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
Irbesartan has been studied across 20 research domains including ❤️ Cardiovascular, 🔥 Metabolic, 🫘 Kidney, 🔬 Inflammation, 🧘 Stress & Anxiety. The primary research focus is ❤️ Cardiovascular with 56% of studies addressing this area.
The following compounds share molecular targets with Irbesartan, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Irbesartan is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.